Archive for November, 2009

ProMox Minoxidil + Topical Finasteride Claims 75% Success Rate

Friday, November 27th, 2009

NOTED HAIR RESTORATION PHYSICIAN ANNOUNCES CLINICALLY PROVEN FORMULA YIELDING UP TO 75% IMPROVEMENT.

Oscar Klein, MD, a well-known hair restoration specialist, has spent years creating formulas providing superior hair growth. Today he announced a breakthrough formula called Promax™. This proprietary formulation showed a 75% rate of improvement in the treatment of alopecia andrognetica (hairloss) in a recent clinical trial. No other topical solution has ever matched these results. The formula works equally well for both the temporal and vertex (front and top) regions of the scalp.

“This is a tremendously significant development for both men and women — those who’ve tried other topical solutions or are attempting to get real results for the first time,” said Dr. Klein. “We’ve not only observed more growth, but the hair itself appears stronger and thicker.”

The FDA approved ingredients formulated in Promax were subjected to six-month triple blind study against Minoxidil™ alone. Minoxidil is currently the most popular topical treatment for hairloss. By contrast, Minoxidil showed only a 25% success rate in this trial over a six-month period.

According to Dr. Klein, “Promax contains reduced qualities of three medications, so the common side effects of each may also be reduced.”

What causes excessive hair loss?

Sunday, November 22nd, 2009

A number of things can cause excessive hair loss. For example, about 3 or 4 months after an illness or a major surgery, you may suddenly lose a large amount of hair. This hair loss is related to the stress of the illness and is temporary.

Hormonal problems may cause hair loss. If your thyroid gland is overactive or underactive, your hair may fall out. This hair loss usually can be helped by treatment thyroid disease. Hair loss may occur if male or female hormones, known as androgens and estrogens, are out of balance. Correcting the hormone imbalance may stop your hair loss.

Many women notice hair loss about 3 months after they’ve had a baby. This loss is also related to hormones. During pregnancy, high levels of certain hormones cause the body to keep hair that would normally fall out. When the hormones return to pre-pregnancy levels, that hair falls out and the normal cycle of growth and loss starts again.

Some medicines can cause hair loss. This type of hair loss improves when you stop taking the medicine. Medicines that can cause hair loss include blood thinners (also called anticoagulants), medicines used for gout, medicines used in chemotherapy to treat cancer, vitamin A (if too much is taken), birth control pills and antidepressants.

Certain infections can cause hair loss. Fungal infections of the scalp can cause hair loss in children. The infection is easily treated with antifungal medicines.

Finally, hair loss may occur as part of an underlying disease, such as lupus or diabetes. Since hair loss may be an early sign of a disease, it is important to find the cause so that it can be treated.

Non-Drinkers More Likely to Be Anxious, Depressed

Wednesday, November 18th, 2009

While alcohol may be considered a depressant, teetotalers as well as heavy drinkers are more likely to suffer from depression and anxiety than moderate tipplers, a new study has found.

Norwegian and British researchers also found that people who don’t drink report having fewer friends than drinkers do, a possible reason for their increased likelihood of being depressed.

“We see that this group is less socially well-adjusted than other groups,” study co-author Dr. Eystein Stordal, an adjunct professor in the Norwegian University of Science and Technology’s neuroscience department, said in a university news release. “Generally when people are with friends, it is more acceptable in Western societies to drink than not to drink. While the questionnaire recorded non-drinkers’ subjective perception of the situation, a number of other studies also confirm that teetotalers experience some level of social exclusion.”

Another possible explanation, the researchers said, had to do with general health of the teetotalers.

“We found on average that there were more people with physical complaints among the non-drinkers than in the other groups,” Stordal said. “These individuals are more likely to use medicines that mean they shouldn’t drink. But it may also be true that having such an illness increases a person’s tendency to be anxious or depressed.”

The study, based on a survey of 38,000 Norwegians and published in the August online edition of the journal Addiction, found high levels of depression and anxiety even when it factored out people who abstained from drinking because of previous problems with alcohol. In all, roughly 17 percent of abstainers reported having anxiety and nearly 16 percent reported having depression.

The researchers also found that people who averaged only two drinks per week reported the fewest bouts with depression or anxiety.

What is the normal cycle of hair growth and loss?

Saturday, November 14th, 2009

The normal cycle of hair growth lasts for 2 to 6 years. Each hair grows approximately 1 centimeter (less than half an inch) per month during this phase. About 90 percent of the hair on your scalp is growing at any one time. About 10 percent of the hair on your scalp, at any one time, is in a resting phase. After 2 to 3 months, the resting hair falls out and new hair starts to grow in its place.

It is normal to shed some hair each day as part of this cycle. However, some people may experience excessive (more than normal) hair loss. Hair loss of this type can affect men, women and children.

Gene Linked to Inherited Kidney Disease Found

Thursday, November 12th, 2009

A genetic mutation associated with inherited kidney disease has been pinpointed by an international team of researchers, who also identified a potential treatment that’s currently being tested in a clinical trial.

The mutation occurs in the gene that encodes the protein renin, which plays an important role in blood pressure regulation. People with this genetic mutation suffer from anemia in childhood and progressive kidney disease, resulting in the need for dialysis, the researchers noted.

The study appears in the Aug. 14 issue of the American Journal of Human Genetics.

“There are many families with inherited kidney disease that do not know the cause and may suffer from this condition. We are interested in helping these families identify the cause of kidney disease that runs in their family,” co-investigator Dr. Anthony Bleyer, a professor of internal medicine-nephrology at Wake Forest University School of Medicine, said in a university news release.

Learning more about how the renin gene mutation affects families with inherited kidney disease will also help researchers better understand how renin works in healthy people. For example, this study revealed that renin plays an important role in maintaining a normal blood count and preventing anemia in children.

Single Kidney Transplant From Young, Deceased Donors Works Well

Wednesday, November 11th, 2009

Adult kidney transplant recipients who receive a single kidney from a very young, deceased donor may do just as well in terms of life expectancy and organ function as those who are given both kidneys, new research has found.

The finding is centered on the controversial issue of how to handle kidney transplants coming from donors 5 years of age or younger, and raises new questions about the common assumption that such kidneys must be transplanted in unison to be viable.

Currently, kidneys taken from children 5 years of age or younger are typically kept together and transplanted as a set into adult recipients, the idea being that splitting up such tiny pediatric organs could undermine the success of the transplant.

By contrast, kidneys taken from donors 10 years of age or older are usually deemed separable. There is no clear protocol regarding kidneys from deceased children between the ages of 5 and 10.

But the new finding suggests that adult patients may fare equally well after receiving just one kidney from a very young donor — an observation that could prove auspicious for the approximately 80,000 Americans currently awaiting a kidney transplant.

“Basically, the normal practice of giving two small kidneys to an adult is unnecessary,” said study author Dr. Rubin Zhang, medical director of kidney and pancreas transplantation at the Tulane University Abdominal Transplant Institute in New Orleans. “It just doesn’t make sense to think of this as if two function better than one, because even though a pediatric kidney will grow larger over time everything else about it in terms of its function is there and fixed at birth. So transplanting two is wasting a lot of kidneys.”

The findings will be published in an upcoming issue of the Clinical Journal of the American Society of Nephrology.

The notion that a single pediatric kidney transplant might be as effective as a double transplant has huge implications, given that an estimated 4,000 American men and women with kidney disease die before a suitable organ becomes available, according to background information in the study.

To assess the viability of single pediatric kidney transplantations, the study authors tracked 79 adult kidney recipients who were patients at Tulane University Abdominal Transplant Institute between 1996 and 2007. During that time, all the adult patients received just one kidney from a deceased donor who was 10 years of age or younger.

Half the adults were given a single kidney from a child between the ages of 5 and 10, while the other half received a kidney from a child who was under the age of 5 — the youngest donor being a 9-month old female.

By most measures, the two groups fared equally well, regardless of the age of the donor child. Both groups were similar in terms of the need for additional surgery following the transplant due to complications, and both experienced comparable rates of kidney rejection and kidney function delays.

Also, kidney function improved along the same trajectory among both groups of recipients during the first three years following transplantation, and both had similar survival rates following surgery.

Zhang and his colleagues noted that the two kidneys from the 9-month-old donor remained healthy and functioning six years after they were transplanted into two separate patients.

The researchers did find that nearly twice as many recipients of kidneys from children younger than 5 had to undergo a urine-drainage procedure following transplantation.

But, the study authors concluded that single kidney transplants from children younger than 5 years old are safe and effective.

Zhang said that he views his finding as definitive, and suggested that “no matter how young the donor — even less than one year — one kidney transplant is enough.”

Dr. Jeremiah Lowney is an internist and medical advisor to a Canton, Mass.-based not-for-profit group called MatchingDonors.com, which seeks to give people in need of transplant surgery an “active way to search for a live organ donor,” according to its Web site. He called the new findings “fantastic news,” while noting that every day approximately 17 Americans die while awaiting a kidney transplant.

“So what we have right now in renal [kidney] transplantation is a supply problem,” Lowney explained. “And it’s actually been getting worse over the years, as the numbers continue to grow. So this study offers a lot of hope, in that this might be one way we can increase the supply of kidneys, and certainly help many more people who are already waiting for a transplant.”

Medication Review May Help With Heart Failure

Tuesday, November 10th, 2009

If doctors and pharmacists work together to ensure that people with heart failure take their medicines correctly, hospitalizations would be less frequent, an Australian study suggests.

In a study of 5,717 people with heart failure, the hospitalization rate for the 273 who had their medications reviewed by doctors and pharmacists was 45 percent lower than the hospitalization rate for the others, whose medicines did not undergo a collaborative review.

People in the study averaged about 82 years old. Those who had their medicines reviewed were slightly sicker and, on average, had more health problems in addition to heart failure than the others — eight vs. seven.

During a year-long follow-up, 5.5 percent of the people in the medication-review group were hospitalized, compared with 12 percent of those in the no-review group.

The study appears online Aug. 18 in Circulation: Heart Failure.

As part of the review, pharmacists visited the participants at home and asked to see all of their prescription and non-prescription drugs. The pharmacists looked for such signs of possible medication misuse as under-dosing, overdosing and hoarding of unneeded medications from previous prescriptions, which can increase the risk of accidentally taking the wrong medicine. They also looked for over-the-counter medications and vitamins that could interact with prescription drugs.

After reviewing the medications, the pharmacist prepared a report for the person’s doctor, who followed up if needed.

A collaborative review system comparable to the one followed in the study has been available in Australia since 2001.

“This is the first study to show these benefits in real-world practice, rather than in a trial setting,” the study’s lead author, Elizabeth E. Roughead, a pharmacist and associate professor in the School of Pharmacy and Medical Sciences at the University of South Australia in Adelaide, said in a news release from the American Heart Association.

“Poor use of medications can increase costs enormously,” she added. “This study indicates that investing in improvements in medication management can result in more cost-effective health care.”